Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 35, Issue 10, Pages 819-836
Publisher
Springer Nature
Online
2012-12-30
DOI
10.1007/bf03261978
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study
- (2011) Martien Wampers et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders
- (2011) Simon Zhornitsky et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Pharmacogenomics of antipsychotics efficacy for schizophrenia
- (2011) Ramón Cacabelos et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Metabolic syndrome with the atypical antipsychotics
- (2011) Pornpoj Pramyothin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Cross-Disorder Genomewide Analysis of Schizophrenia, Bipolar Disorder, and Depression
- (2010) Jie Huang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Amisulpride Versus Olanzapine in the Treatment of Schizophrenia in Indian Patients: Randomized Controlled Trial
- (2010) Subhrojyoti Bhowmick et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability?
- (2010) Odette L.J. Peerbooms et al. BRAIN BEHAVIOR AND IMMUNITY
- Olanzapine Long-Acting Injection
- (2010) James E. Frampton DRUGS
- Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients
- (2010) Kristina I. Melkersson et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Severe Hyperglycemia Induced by Olanzapine was Improved with a Recovery of Insulin Secretion after Switching to Risperidone and Introducing Insulin Therapy
- (2010) Masaru Nakamura et al. INTERNAL MEDICINE
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Effect of Antipsychotic Medications on Glucose and Lipid Levels
- (2010) Parminder S. Chaggar et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis
- (2010) V L Albaugh et al. MOLECULAR PSYCHIATRY
- Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics
- (2010) Y-J Liou et al. PHARMACOGENOMICS JOURNAL
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics
- (2010) Ya Mei Bai et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
- (2009) S. M. Stahl et al. ACTA PSYCHIATRICA SCANDINAVICA
- Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder
- (2009) Thomas Munk Laursen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Asenapine versus olanzapine in acute mania: a double-blind extension study
- (2009) Roger S McIntyre et al. BIPOLAR DISORDERS
- A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
- (2009) Roger S McIntyre et al. BIPOLAR DISORDERS
- Weight gain, obesity, and metabolic indices following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)
- (2009) David J. Bond et al. JOURNAL OF AFFECTIVE DISORDERS
- Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania
- (2009) Mauricio Tohen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances
- (2009) Ruud van Winkel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder
- (2009) Ruud van Winkel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comorbid Somatic Illnesses in Patients With Severe Mental Disorders
- (2009) W. Wolfgang Fleishhacker et al. JOURNAL OF CLINICAL PSYCHIATRY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia
- (2009) Keming Gao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
- (2009) Arzu Gunes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Weight effects associated with antipsychotics: A comprehensive database analysis
- (2009) Bruce Parsons et al. SCHIZOPHRENIA RESEARCH
- Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder
- (2008) Mauricio Tohen et al. JOURNAL OF AFFECTIVE DISORDERS
- A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism
- (2008) HY Chan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search